Adhera Therapeutics, Inc. ATRX
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.0001 Day range 0.0001
0.0001 52-week range 0.0001
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 722
- Vol
- 84.00K
- Avg vol
- 312
- EPS
- -1.18
- P/E
- 0.00
More statistics
- Low
- 0.0001
- High
- 0.0001
- Earnings
- Mar 31, 2023
2Y chart
Signals (8)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 27, 2025 | 1 year ago |
| SMA: Bearish | Oct 7, 2025 | 1 year ago |
| SMA: Bearish | Oct 7, 2025 | 1 year ago |
| RSI: Oversold | Oct 7, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 3, 2025 | 1 year ago |
| RSI: Overbought | Aug 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 17, 2025 | 1 year ago |
| RSI: Oversold | Dec 20, 2024 | 1 year ago |
Next earnings
Mar 31, 2023
Expected Mar 31, 2023. Consensus EPS estimate 0.00.
Financials — quick view
ATRX Revenue — quarterly 0
ATRX Net income — quarterly 99.00K
ATRX EPS — quarterly -0.01
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 20, 2023 | Sep 1, 2023 | 0.00 | -0.83 | — | — |
| Aug 21, 2023 | Jun 1, 2023 | 0.00 | -0.01 | — | — |
| May 22, 2023 | Mar 1, 2023 | 0.00 | -0.29 | — | — |
| Mar 31, 2023 | Dec 1, 2022 | 0.00 | — | — | — |
| Nov 14, 2022 | Sep 1, 2022 | 0.00 | -0.57 | — | — |
| Aug 15, 2022 | Jun 1, 2022 | 0.00 | -0.20 | — | — |
News
- CG Oncology (NASDAQ:CGON) vs. Adhera Therapeutics (OTCMKTS:ATRX) Critical Survey
- Manufacturing Commences on Adhera's MLR-1019 for Phase 2a Clinical Trial Treating Parkinson's Disease
- 7 Biotech Penny Stocks With Huge Catalysts Coming in 2022
- Adhera Receives European Patent Covering MLR-1019 and Derivatives for Treating Dyskinesias
- Stocks That Hit 52-Week Highs On Tuesday
Your note
Sign in to keep a note on ATRX — it syncs with the Stock Master app.